BIOFRONTERA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.312 EUR | 0.00% |
|
+6.85% | -23.90% |
| Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
Chart calendar Biofrontera AG
6616a7887d072ccda.sFBBpyCMwKQtR8qFdgNhwkklaZbRLS7z5iXYoc6iR0Y.-ml10W7duvEeMvrcOWhXjgNiCKeEdEahgRbg96_JPhPdBmz2Srm5_GIVmw~8d61aa94ef892aced74b5b8b87a88d42
Upcoming events on Biofrontera AG
Past events on Biofrontera AG
| 2024-04-24 | Q4 2023 Earnings Release (Projected) |
| 2023-08-31 04:00 am | Q2 2023 Earnings Release |
| 2023-06-20 05:30 am | Annual General Meeting |
| 2023-05-31 08:00 am | Q1 2023 Earnings Call |
| 2023-05-31 05:30 am | Q1 2023 Earnings Release |
| 2023-04-27 05:20 pm | Q4 2022 Earnings Release |
| 2022-11-22 | Q3 2022 Earnings Release |
| 2022-10-27 | Rights Issue: 1 new share @ 1 EUR for 8 existing shares |
| 2022-08-23 05:00 am | Annual General Meeting |
| 2022-08-17 | Interim 2022 Earnings Release |
| 2022-05-19 08:00 am | Q1 2022 Earnings Call |
| 2022-05-17 10:20 am | Q1 2022 Earnings Release |
| 2022-05-02 08:00 am | FY 2021 Earnings Call |
| 2022-04-27 | FY 2021 Earnings Release |
| 2021-12-14 04:00 am | Annual General Meeting |
| 2021-11-21 | Analyst Conference |
| 2021-11-18 08:00 am | Q3 2021 Earnings Call |
| 2021-11-17 05:00 pm | Q3 2021 Earnings Release |
| 2021-08-20 08:00 am | Interim 2021 Earnings Call |
| 2021-08-19 11:46 am | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 31,3 31,3 0.05% | 30,3 30,3 0.04% | 28,8 28,9 -0.22% | 25,7 27,0 -4.67% |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -32,1 -31,2 -2.73% | 1,87 3,90 -52.08% |
|
EBIT Million EUR | Released Forecast Spread | -23,4 -23,8 1.64% | -7,61 -9,43 19.32% | -35,3 -35,4 0.17% | 1,12 3,10 -63.74% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,78 -5,25 9.01% | -12,7 -12,8 0.8% | 35,7 -37,8 194.52% | -43,2 -42,1 -2.64% |
|
Net income Million EUR | Released Forecast Spread | -7,36 -5,25 -40.15% | -13,0 -13,1 0.33% | 38,3 -32,1 219.37% | -44,2 -42,1 -4.91% |
|
EPS EUR | Released Forecast Spread | -0,16 -0,12 -33.33% | -0,24 -0,28 12.73% | 0,68 -0,46 247.83% | -0,77 -0,59 -30.51% |
| Announcement Date | 20/04/20 | 12/04/21 | 30/04/22 | 28/04/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 10,3 10,4 -0.83% | 6,57 9,70 -32.31% | 8,51 10,4 -18.17% |
|
EBIT Million EUR | Released Forecast Spread | -22,8 -22,8 0.14% | 1,15 | |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 50,3 -23,3 315.93% | -28,1 -5,10 -450.98% | -7,96 -5,40 -47.43% |
|
Net income Million EUR | Released Forecast Spread | 53,0 -23,3 327.42% | -28,1 -5,10 -450.98% | -8,65 -5,40 -60.09% |
| Announcement Date | 30/04/22 | 17/05/22 | 19/08/22 |
More events
Past sector events for Biofrontera AG
| 2024-05-03 07:07 am | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 2024-05-03 06:00 am | AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
| 2024-05-02 04:01 pm | AMGEN INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:43 pm | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 2024-05-02 07:30 am | ORGANON & CO.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 2024-05-02 01:30 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 2024-05-01 | GC BIOPHARMA CORP.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- B8F Stock
- B8F Stock
- Calendar Biofrontera AG
